Author

Favour Peters

Institution: University of Cambridge

Observed institutions: University of Cambridge, Kwame Nkrumah University of Science and Technology

ORCID: 0000-0003-0125-6828

Observed ORCID: 0000-0003-0125-6828

OpenAlex ID: A5034549979

RETRACTED ARTICLE: Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and COVID-19

2025 · Adewunmi Akingbola, Abiodun Adegbesan, et al. · npj Vaccines · 13

Genomic Evolution and Epidemiological Impact of Ongoing Clade Ib MPox Disease: A Narrative Review

2025 · Adewunmi Akingbola, Adegbesan Abiodun, et al. · Global Health · 10

From Wuhan to Omicron K.P2 strain: A comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine

2025 · Adewunmi Akingbola, Olajumoke Adewole, et al. · Human Vaccines & Immunotherapeutics · 7

Prevalence and Correlates of Postpartum Depression Among Nursing Mothers Within the Kumasi Metropolis

2024 · Favour Peters, Hasehni Vampere, et al. · Journal of Science and Technology (Ghana) · 2

Prevalence and Correlates of Postpartum Depression among Nursing Mothers within the Kumasi Metropolis: An Analytical Cross-sectional Study

2022 · Favour Peters, Elias Hormeku, et al. · Research Square · 1

A narrative review of filovirus outbreaks in East Africa: lessons for strengthening regional disease surveillance

2026 · Adewunmi Akingbola, Abiodun Adegbesan, et al. · Tropical Medicine and Health

Retraction Note: Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and COVID-19

2025 · Adewunmi Akingbola, Abiodun Adegbesan, et al. · npj Vaccines

Works count: 7

Citation count: 33

H-index: 3

I10-index: 2